Develop Rapid Subject Enrollment Solutions for Phase II and III Studies

We provide clients with Rapid Patient Enrollment Solutions for Phase II and III studies by using Investigational Sites across the globe, especially in emerging markets. Our team has the ability to overcome regulatory hurdles and ensure trials are rapidly enrolled. The number of trials being performed in emerging markets is increasing as pharmaceutical companies awake to these markets’ advantages.

Our particular expertise includes:

Help evaluate patient population for a particular indication and determine best sites in the US and overseas
Help select and oversee CRO in these regions that is best qualified to meet Sponsors specific needs
Oversee trials on behalf of Sponsor and ensure sponsor enrollment targets and regulatory and data quality requirements are met
Establish presence for Sponsor in the above geographies to meet drug development and marketing goals

We specialize in partnering with Pharmaceutical, Biotechnology and Medical Device firms to Design & Execute Clinical Trials, integrate Rapid Patient Enrollment Solutions into clinical trials, and Rescue Clinical Trials/Address Delayed FDA Submissions.